LRG1 is an independent prognostic factor for endometrial carcinoma

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 7125-7133

  Wen, Shan Yun ^a,b,c   Zhang, Li Na ^c   Yang, Xiao Mei ^c   Zhang, Yan Li ^c   Ma, Li ^a   Ge, Qiu Lin ^a   Jiang, Shu Heng ^c   Zhu, Xiao Lu ^a   Xu, Wei ^a   Ding, Wen Jing ^a   Yang, Bing Qing ^a   Zhang, Zhi Gang ^c   Teng, Yin Cheng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Songjiang District Central Hospital   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Endometrial carcinoma; LRG1; Prognosis

Indexed keywords

GLYCOPROTEIN; LEUCINE RICH ALPHA2 GLYCOPROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; VALIDITY;

ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS;

EID: 84904972889     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1953-6     Document Type: Article

References (30)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.
2. Creutzberg CL, van Putten WLJ, Koper PC, Lybeert MLM, Jobsen JJ, Wárlám-Rodenhuis CC, et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol. 2003;89:201-9. (Pubitemid 36457866)
3. Li J, Yang XM, Wang YH, Feng MX, Liu XJ, Zhang YL, et al. Monoamine oxidase a suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of egfr signaling. J Hepatol. 2014. doi:10.1016/j.jhep.2014.02.025.
4. Lu P, Weaver VM, Werb Z. The extracellularmatrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196:395-406.
5. 〈structural and functional diversity in the leucine-rich repeat family of proteins.Pdf〉
6. Cummings C, Walder J, Treeful A, Jemmerson R. Serumleucine-rich alpha-2-glycoprotein-1 binds cytochrome c and inhibits antibody detection of this apoptotic marker in enzyme-linked immunosorbent assay. Apoptosis. 2006;11:1121-9. (Pubitemid 44035961)
7. Thompson FC. The vietnam war added a motive to go on studying. Nature. 2007;449:139. (Pubitemid 47402343)
8. Serada S, Fujimoto M, Terabe F, Iijima H, Shinzaki S, Matsuzaki S, et al. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. Inflamm Bowel Dis. 2012;18:2169-79.
9. Kentsis A, Ahmed S, Kurek K, Brennan E, Bradwin G, Steen H, et al. Detection and diagnostic value of urine leucine-rich α-2-glycoprotein in children with suspected acute appendicitis. Ann Emerg Med. 2012;60:78-83.e71.
10. Hütter G, Neumann M, Nowak D, Klein S, Klüter H, Hofmann W-K. The effect of the ccr5-delta32 deletion on global gene expression considering immune response and inflammation. J Inflamm. 2011;8:29.
11. Ladd JJ, Busald T, Johnson MM, Zhang Q, Pitteri SJ, Wang H, et al. Increased plasma levels of the apc-interacting protein mapre1, lrg1, and igfbp2 preceding a diagnosis of colorectal cancer in women. Cancer Prev Res (Phila). 2012;5:655-64.
12. Weivoda S, Andersen JD, Skogen A, Schlievert PM, Fontana D, Schacker T, et al. Elisa for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand. J Immunol Methods. 2008;336:22-9.
13. Shirai R, Hirano F, Ohkura N, Ikeda K, Inoue S. Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response. Biochem Biophys Res Commun. 2009;382:776-9.
14. He X, Wang Y, Zhang W, Li H, Luo R, Zhou Y, et al. Screening differential expression of serum proteins in afp-negative hbv-related hepatocellular carcinoma using iTRAQ - MALDI-MS/MS. Neoplasma. 2013;61:17-26.
15. Wu J, Xie X, Nie S, Buckanovich RJ, Lubman DM. Altered expression of sialylated glycoproteins in ovarian cancer sera using lectin-based elisa assay and quantitative glycoproteomics analysis. J Proteome Res. 2013;12:3342-52.
16. Uen YH, Lin KY, Sun DP, Liao CC, Hsieh MS, Huang YK, et al. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma con a-bound glycoprotein biomarkers in gastric cancer. J Proteomics. 2013;83:197-213.
17. Wu RC, Yu CS, Liu KC, Huang HY, Ip SW, Lin JP, et al. Citosol (thiamylal sodium) triggers apoptosis and affects gene expressions of murine leukemia raw 264.7 cells. Hum Exp Toxicol. 2012;31:771-9.
18. Kakisaka T, Kondo T, Okano T, Fujii K, Honda K, Endo M, et al. Plasma proteomics of pancreatic cancer patients by multidimensional liquid chromatography and two-dimensional difference gel electrophoresis (2d-dige): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. J Chromatogr B Anal Technol Biomed Life Sci. 2007;852:257-67. (Pubitemid 46830120)
19. Linden M, Segersten U, Runeson M, Wester K, Busch C, Pettersson U, et al. Tumour expression of bladder cancer-associated urinary proteins. BJU Int. 2013;112:407-15.
20. Liu Y, Luo X, Hu H, Wang R, Sun Y, Zeng R, et al. Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer. PLoS One. 2012;7:e51748.
21. Hatzfeld M, Lynch J, Meehan MH, Crean J, Copeland J, Stallings RL, et al. Metastasis suppressor microrna-335 targets the formin family of actin nucleators. PLoS One. 2013;8:e78428.
22. Wang X, Abraham S, McKenzie JAG, Jeffs N, Swire M, Tripathi VB, et al. Lrg1 promotes angiogenesis by modulating endothelial tgf-β signalling. Nature. 2013;499:306-11.
23. Lynch J, Fay J, Meehan M, Bryan K, Watters KM, Murphy DM, et al. Mirna-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical tgf- signalling pathway. Carcinogenesis. 2012;33:976-85.
24. O'Donnell LC, Druhan LJ, Avalos BR. Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation. J Leukoc Biol. 2002;72:478-85.
25. Lim YY, Wright JA, Attema JL, Gregory PA, Bert AG, Smith E, et al. Epigenetic modulation of the mir-200 family is associated with transition to a breast cancer stem-cell-like state. J Cell Sci. 2013;126:2256-66.
26. Mitra AK, Zillhardt M, Hua Y, Tiwari P, Murmann AE, Peter ME, et al. Micrornas reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov. 2012;2:1100-8.
27. Wen SY, Lin Y, Yu YQ, Cao SJ, Zhang R, Yang XM, et al. Mir-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor gli3 in human cervical cancer. Oncogene. 2014. doi:10.1038/onc.2014.9.
28. Ng EK, Li R, Shin VY, Siu JM, Ma ES, Kwong A. Microrna-143 is downregulated in breast cancer and regulates DNA methyltransferases 3a in breast cancer cells. Tumour Biol. 2013;35(3):2591-8.
29. Angioli R, Plotti F, Capriglione S, Montera R, Damiani P, Ricciardi R, et al. The role of novel biomarker he4 in endometrial cancer: a case control prospective study. Tumour Biol. 2013;34:571-6.
30. Gillott D, Alrumaih H, Leung K, Eldib A, Grudzinskas J. Specific isoforms of leucine-rich α2-glycoprotein detected in the proliferative endometrium of women undergoing assisted reproduction are associated with spontaneous pregnancy. Fertil Steril. 2008;90:761-8. Municipality